Search

Chandrika Prasad

Examiner (ID: 17499, Phone: (571)272-2099 , Office: P/2831 )

Most Active Art Unit
2839
Art Unit(s)
2833, 2839, 2831
Total Applications
2897
Issued Applications
2445
Pending Applications
55
Abandoned Applications
397

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6683859 [patent_doc_number] => 20030119723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides' [patent_app_type] => new [patent_app_number] => 10/287195 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18643 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119723.pdf [firstpage_image] =>[orig_patent_app_number] => 10287195 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/287195
Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides Nov 3, 2002 Abandoned
Array ( [id] => 6846837 [patent_doc_number] => 20030166004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Endothelial-cell binding peptides for diagnosis and therapy' [patent_app_type] => new [patent_app_number] => 10/286457 [patent_app_country] => US [patent_app_date] => 2002-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 28214 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166004.pdf [firstpage_image] =>[orig_patent_app_number] => 10286457 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/286457
Endothelial-cell binding peptides for diagnosis and therapy Oct 31, 2002 Abandoned
Array ( [id] => 6669402 [patent_doc_number] => 20030114386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Hexa-, hepta-, and octapeptides having antiangiogenic activity' [patent_app_type] => new [patent_app_number] => 10/283553 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15822 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114386.pdf [firstpage_image] =>[orig_patent_app_number] => 10283553 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/283553
Hexa-, hepta-, and octapeptides having antiangiogenic activity Oct 29, 2002 Issued
Array ( [id] => 6843606 [patent_doc_number] => 20030148953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Inactivation resistant factor VIII' [patent_app_type] => new [patent_app_number] => 10/283648 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 17913 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148953.pdf [firstpage_image] =>[orig_patent_app_number] => 10283648 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/283648
Inactivation resistant factor VIII Oct 28, 2002 Abandoned
Array ( [id] => 6861619 [patent_doc_number] => 20030092627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Pharmaceutical composition comprising a factor VIIa and a factor XIII' [patent_app_type] => new [patent_app_number] => 10/271278 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11858 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092627.pdf [firstpage_image] =>[orig_patent_app_number] => 10271278 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/271278
Pharmaceutical composition comprising a factor VIIa and a factor XIII Oct 14, 2002 Abandoned
Array ( [id] => 7206451 [patent_doc_number] => 20040087498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Modified factor VII' [patent_app_type] => new [patent_app_number] => 10/263205 [patent_app_country] => US [patent_app_date] => 2002-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17479 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087498.pdf [firstpage_image] =>[orig_patent_app_number] => 10263205 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/263205
Modified factor VII Sep 30, 2002 Abandoned
Array ( [id] => 6801201 [patent_doc_number] => 20030096366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Method for production of recombinant proteins in eukaryote cells' [patent_app_type] => new [patent_app_number] => 10/254394 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9834 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096366.pdf [firstpage_image] =>[orig_patent_app_number] => 10254394 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/254394
Method for production of recombinant proteins in eukaryote cells Sep 24, 2002 Abandoned
Array ( [id] => 6788333 [patent_doc_number] => 20030139572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Novel compounds' [patent_app_type] => new [patent_app_number] => 10/239663 [patent_app_country] => US [patent_app_date] => 2002-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14668 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139572.pdf [firstpage_image] =>[orig_patent_app_number] => 10239663 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/239663
Novel compounds Sep 23, 2002 Abandoned
Array ( [id] => 6656655 [patent_doc_number] => 20030077753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Diglycosylated erythropoietin' [patent_app_type] => new [patent_app_number] => 10/241356 [patent_app_country] => US [patent_app_date] => 2002-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5573 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077753.pdf [firstpage_image] =>[orig_patent_app_number] => 10241356 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/241356
Diglycosylated erythropoietin Sep 10, 2002 Issued
Array ( [id] => 6861131 [patent_doc_number] => 20030092139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Process for the fermentative preparation of L-amino acids using coryneform bacteria' [patent_app_type] => new [patent_app_number] => 10/212219 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6084 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092139.pdf [firstpage_image] =>[orig_patent_app_number] => 10212219 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/212219
Process for the fermentative preparation of L-amino acids using coryneform bacteria Aug 5, 2002 Abandoned
Array ( [id] => 6706319 [patent_doc_number] => 20030153053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Methods for altering polyketide synthase genes' [patent_app_type] => new [patent_app_number] => 10/214424 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4173 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153053.pdf [firstpage_image] =>[orig_patent_app_number] => 10214424 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/214424
Methods for altering polyketide synthase genes Aug 5, 2002 Abandoned
Array ( [id] => 6683863 [patent_doc_number] => 20030119727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'FVIIa antagonists' [patent_app_type] => new [patent_app_number] => 10/202915 [patent_app_country] => US [patent_app_date] => 2002-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 26822 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119727.pdf [firstpage_image] =>[orig_patent_app_number] => 10202915 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/202915
FVIIa antagonists Jul 24, 2002 Issued
Array ( [id] => 761356 [patent_doc_number] => 07012132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-14 [patent_title] => 'Modified factor VIII' [patent_app_type] => utility [patent_app_number] => 10/187319 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 31128 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/012/07012132.pdf [firstpage_image] =>[orig_patent_app_number] => 10187319 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/187319
Modified factor VIII Jun 27, 2002 Issued
Array ( [id] => 7199367 [patent_doc_number] => 20040086501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Protein having activity as an angiogenesis modulator' [patent_app_type] => new [patent_app_number] => 10/019065 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8813 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086501.pdf [firstpage_image] =>[orig_patent_app_number] => 10019065 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/019065
Protein having activity as an angiogenesis modulator May 30, 2002 Abandoned
10/031947 Multi-dose erythropoietin formulations May 14, 2002 Abandoned
Array ( [id] => 758032 [patent_doc_number] => 07015193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-21 [patent_title] => 'Compositions and methods to control bleeding' [patent_app_type] => utility [patent_app_number] => 10/125950 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 26 [patent_no_of_words] => 13983 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015193.pdf [firstpage_image] =>[orig_patent_app_number] => 10125950 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/125950
Compositions and methods to control bleeding Apr 18, 2002 Issued
Array ( [id] => 6656653 [patent_doc_number] => 20030077751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Zvwf1: a member of the von Willebrand factor type a domain superfamily' [patent_app_type] => new [patent_app_number] => 10/127101 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30001 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077751.pdf [firstpage_image] =>[orig_patent_app_number] => 10127101 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/127101
Zvwf1: a member of the von Willebrand factor type a domain superfamily Apr 18, 2002 Abandoned
Array ( [id] => 6701484 [patent_doc_number] => 20030224364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci' [patent_app_type] => new [patent_app_number] => 10/107431 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 46176 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224364.pdf [firstpage_image] =>[orig_patent_app_number] => 10107431 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/107431
Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci Mar 27, 2002 Abandoned
Array ( [id] => 6377606 [patent_doc_number] => 20020119487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Human stem cell antigen 2' [patent_app_type] => new [patent_app_number] => 10/101747 [patent_app_country] => US [patent_app_date] => 2002-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12612 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119487.pdf [firstpage_image] =>[orig_patent_app_number] => 10101747 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/101747
Human stem cell antigen 2 Mar 20, 2002 Abandoned
Array ( [id] => 6158784 [patent_doc_number] => 20020147148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Insecticidal protein toxins from xenorhabdus' [patent_app_type] => new [patent_app_number] => 10/078968 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16043 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147148.pdf [firstpage_image] =>[orig_patent_app_number] => 10078968 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/078968
Insecticidal protein toxins from xenorhabdus Feb 18, 2002 Abandoned
Menu